AVITA Medical Reports Strong Q2, Raises 2026 Revenue Guidance, and Targets Q4 Cash Flow Breakeven
RCEL sits 68% above its 52-week low of $3.22.
Summary
AVITA Medical reported strong second-quarter results with significant revenue growth and reduced net loss, raising its full-year 2026 revenue guidance and projecting cash flow breakeven by Q4 2026, directly addressing prior liquidity concerns.
Key Events · Earnings and Guidance · RCEL
-
Strong Q2 Financial Performance
Net revenue grew 18% year-over-year and 13% sequentially to a record $21.7 million, with gross profit margin increasing to 81.9%.
-
Improved Cash Burn & Breakeven Outlook
Net cash use significantly improved to $3.2 million from $9.9 million in Q1 2026, with the company now expecting to reach cash flow breakeven in Q4 2026.
-
Raised Full-Year Revenue Guidance
Full-year 2026 net revenue guidance was increased to a range of $86 million to $89 million, up from the previous $80 million to $85 million.
-
Positive CMS Reimbursement Update
The Centers for Medicare & Medicaid Services proposed national physician payment for RECELL in 2027, along with increased hospital outpatient and ambulatory surgical center facility payment rates.
Analysis · RCEL · Industrial Applications And Services
This filing is highly important as AVITA Medical has delivered strong Q2 financial results, significantly improving its operational performance and financial outlook. The company's ability to raise full-year revenue guidance and project cash flow breakeven by Q4 2026 directly addresses the "going concern" warning issued in the prior quarter's 10-Q. This indicates a substantial improvement in the company's financial stability and operational execution, reducing near-term liquidity risks and potentially altering the investment thesis.
At the time of this filing, RCEL was trading at $5.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $146.2M. The 52-week trading range was $3.22 to $7.12. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.